![Andrius Žučenka: Stop by at our EHA2024 poster on relapsed/refractory AML](https://oncodaily.com/pub/uploads/2024/06/Pi7_Tool_maxresdefault-e1718490888957.jpg)
Photo of Andrius Žučenka from vjhemonc.com
Jun 16, 2024, 02:39
Andrius Žučenka: Stop by at our EHA2024 poster on relapsed/refractory AML
Andrius Žučenka, Head of The Department of Specialized Care For Immunocompromised Patients at VUL Santaros Klinikos, shared a post on X:
“Please stop by at our EHA2024 poster P1325 with the results of the non-intensive, targeted therapy-based preconditioning regimens followed by standard conditioning and alloSCT in relapsed/refractory AML/HR-MDS patients with active disease (including TP53m/post-Ven).”
Source: Andrius Žučenka/X
Jun 24, 2024, 08:05